Cardiome Pharma Shares Outstanding 2006-2019 | CORV

Cardiome Pharma shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Cardiome Pharma Annual Shares Outstanding
(Millions of Shares)
2018 35
2017 33
2016 25
2015 18
2014 16
2013 13
2012 12
2011 12
2010 12
2009 13
2008 13
2007 13
2006 11
2005 10
Cardiome Pharma Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 39
Q4 2018 35
Q3 2018 35
Q2 2018 35
Q1 2018 35
Q4 2017 33
Q3 2017 34
Q2 2017 32
Q1 2017 32
Q4 2016 25
Q3 2016 28
Q2 2016 20
Q1 2016 20
Q4 2015 20
Q3 2015 19
Q2 2015 17
Q1 2015 17
Q4 2014 17
Q3 2014 17
Q2 2014 17
Q1 2014 15
Q4 2013 14
Q3 2013 12
Q2 2013 13
Q1 2013 13
Q4 2012 12
Q3 2012 12
Q2 2012 13
Q1 2012 13
Q4 2011 12
Q3 2011 12
Q2 2011 12
Q1 2011 12
Q4 2010 12
Q3 2010 12
Q2 2010 12
Q1 2010 12
Q4 2009 12
Q3 2009 13
Q2 2009 14
Q1 2009 13
Q4 2008 13
Q3 2008 13
Q2 2008 13
Q1 2008 13
Q4 2007 13
Q3 2007 13
Q2 2007 13
Q1 2007 12
Q4 2006 11
Q3 2006 11
Q2 2006
Q1 2006 11
Q4 2005 10
Q3 2005 10
Q2 2005 10
Q1 2005 8
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.097B $0.029B
Correvio Pharma Corp. operates as a pharmaceutical company. It develops and discovers cardiovascular drugs for the treatment of atrial arrhythmia, congestive heart failure and bacterial skin infections. The company's product portfolio includes BRINAVESS(R), AGGRASTAT(R), ESMOCARD(R), ESMOCARDLYO(R), EXEMBOL(R) and XYDALBA(TM). Correvio Pharma Corp., formerly known as Correvio Pharma Corp., is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.196B 37.07
Astellas Pharma (ALPMY) Japan $26.780B 13.13
Takeda Pharmaceutical (TAK) Japan $26.201B 8.18
Grifols, S.A (GRFS) Spain $15.161B 19.34
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.716B 25.30
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.973B 21.51
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $8.886B 0.00
IPSEN SA ADR (IPSEY) France $8.634B 0.00
Sage Therapeutics (SAGE) United States $8.507B 0.00
Catalent (CTLT) United States $8.127B 32.61
Jazz Pharmaceuticals (JAZZ) Ireland $7.726B 10.17
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.954B 17.81
FibroGen (FGEN) United States $3.877B 96.98
United Therapeutics (UTHR) United States $3.565B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.140B 11.25
Evotec AG (EVTCY) Germany $3.032B 41.51
Nektar Therapeutics (NKTR) United States $2.999B 0.00
Tilray (TLRY) Canada $2.849B 0.00
PTC Therapeutics (PTCT) United States $2.695B 0.00
Xencor (XNCR) United States $2.309B 50.35
Zogenix (ZGNX) United States $2.148B 0.00
Portola Pharmaceuticals (PTLA) United States $1.974B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.580B 57.50
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
USANA Health Sciences (USNA) United States $1.491B 14.95
Corcept Therapeutics (CORT) United States $1.468B 20.17
Heron Therapeutics (HRTX) United States $1.437B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.424B 23.49
Ironwood Pharmaceuticals (IRWD) United States $1.380B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.218B 0.00
ArQule (ARQL) United States $1.110B 0.00
Radius Health (RDUS) United States $1.059B 0.00
Aerie Pharmaceuticals (AERI) United States $1.034B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.919B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.828B 3.69
Endo (ENDP) Ireland $0.684B 1.20
TherapeuticsMD (TXMD) United States $0.661B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.636B 0.00
Indivior (INVVY) United States $0.575B 2.08
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.540B 0.00
Akebia Therapeutics (AKBA) United States $0.534B 0.00
Dermira (DERM) United States $0.482B 0.00
Concordia (CXRXF) Canada $0.479B 0.00
Aptorum Group (APM) China $0.464B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.457B 0.00
Translate Bio (TBIO) United States $0.443B 0.00
Dova Pharmaceuticals (DOVA) United States $0.429B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.427B 19.43
ChemoCentryx (CCXI) United States $0.410B 0.00
ImmunoGen (IMGN) United States $0.409B 0.00
Flexion Therapeutics (FLXN) United States $0.407B 0.00
Siga Technologies (SIGA) United States $0.405B 0.95
Organogenesis Holdings (ORGO) United States $0.400B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.365B 0.00
CV Sciences (CVSI) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.323B 0.00
Xeris Pharmaceuticals (XERS) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.290B 0.00
Rafael Holdings (RFL) United States $0.282B 0.00
Harpoon Therapeutics (HARP) United States $0.280B 0.00
CannTrust Holdings (CTST) Canada $0.277B 0.00
Lannett Co Inc (LCI) United States $0.277B 2.69
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
DURECT (DRRX) United States $0.263B 0.00
OptiNose (OPTN) United States $0.263B 0.00
Recro Pharma (REPH) United States $0.259B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.251B 0.00
Concert Pharmaceuticals (CNCE) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.218B 0.00
Calithera Biosciences (CALA) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.197B 0.00
Molecular Templates (MTEM) United States $0.185B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 29.26
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.155B 0.00
GlycoMimetics (GLYC) United States $0.146B 0.00
IMV INC (IMV) Canada $0.145B 0.00
Generex Biotechnology (GNBT) United States $0.137B 0.00
Majesco Entertainment (PTE) United States $0.133B 0.00
Jounce Therapeutics (JNCE) United States $0.123B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
MEI Pharma (MEIP) United States $0.120B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.114B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.111B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
AgeX Therapeutics (AGE) United States $0.101B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Aquestive Therapeutics (AQST) United States $0.095B 0.00
Neos Therapeutics (NEOS) United States $0.094B 0.00
Iterum Therapeutics (ITRM) Ireland $0.094B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.086B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.94
Genocea Biosciences (GNCA) United States $0.083B 0.00
MediWound (MDWD) Israel $0.080B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.078B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
Otonomy (OTIC) United States $0.072B 0.00
China SXT Pharmaceuticals (SXTC) China $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 589.00
Infinity Pharmaceuticals (INFI) United States $0.068B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.063B 0.00
SCYNEXIS (SCYX) United States $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.060B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
Capnia (SLNO) United States $0.060B 0.00
Lipocine (LPCN) United States $0.060B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
India Globalization Capital (IGC) United States $0.040B 0.00
CTI BioPharma (CTIC) United States $0.040B 0.00
Aclaris Therapeutics (ACRS) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Melinta Therapeutics (MLNT) United States $0.034B 0.00
PharmAthene (ALT) United States $0.033B 0.00
Biomerica (BMRA) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.023B 0.00
IsoRay (ISR) United States $0.023B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.44
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.007B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00